Pramiconazole
From Self-sufficiency
| File:Pramiconazole.png | |
| Systematic (IUPAC) name | |
|---|---|
|
1-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one | |
| Identifiers | |
| ATC code | none |
| PubChem | CID 11411233 |
| Chemical data | |
| Formula | C35H39F2N7O4 |
| Molar mass | 659.725 g/mol[[Script error: No such module "String".]] |
Pramiconazole is a triazole antifungal undergoing research for the treatment of acute skin and mucosal fungal infections.
It is developed by Barrier Therapeutics.
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Antifungals
- Triazoles
- Organofluorides
- Dioxolanes
- Phenol ethers
- Piperazines
- Ureas
- Imidazolidinones
- 2Fix
